首页> 美国卫生研究院文献>Diabetology international >Drug development research for novel adiponectin receptor-targeted antidiabetic drugs contributing to healthy longevity
【2h】

Drug development research for novel adiponectin receptor-targeted antidiabetic drugs contributing to healthy longevity

机译:新型脂联素受体靶向抗糖尿病药物的药物开发研究有助于健康寿命

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Scheme illustrating the actions of adiponectin/AdipoR agonist, AdipoRon, in the liver and the muscle. Adiponectin and the AdipoR agonist, AdipoRon participate in the regulation of glucose and lipid metabolism through their critical effects within the liver and muscle. In the liver, adiponectin/AdipoRon activates not only the AMPK pathway via AdipoR1 but the PPARα pathways via AdipoR2, thus doubly ameliorating insulin resistance and steatosis [17, 18]. In the muscle, adiponectin/AdipoRon regulates PGC-1α through the AMPK-SIRT1 and the calcium-CaMKK pathways to promote mitochondrial biogenesis via AdipoR1 [18, 41]
机译:说明脂联素/ adipor激动剂,脂肪,肝脏和肌肉中的作用的方案。脂联素和Adipor激动剂,Adiporon通过肝脏和肌肉中的临界作用参与调节葡萄糖和脂质代谢。在肝脏中,脂联素/ adiporon不仅通过Adipor1激活AMPK途径,而是通过Adipor2的PPARα途径,因此双重改善胰岛素抵抗和脂肪变性[17,18]。在肌肉中,Adiponectin / adiporon通过AMPK-SIRT1调节PGC-1α和钙 - Camkk途径,通过Adipor1促进线粒体生物粒子[18,41]

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号